MELVILLE, N.Y., Sept. 17 /PRNewswire-FirstCall/ — Henry Schein,
Inc., (Nasdaq:
HSIC), the largest provider of health care products and
services to office-based practitioners, announced today that Steven
Paladino, Henry Schein’s Executive Vice President and Chief
Financial Officer, will present at the UBS Global Life Sciences
Conference at the Grand Hyatt New York.
Henry Schein’s presentation is scheduled to begin at 9 a.m. EDT
and can be heard via live webcast by visiting www.henryschein.com,
clicking on “Investor Relations” and following the link for
“Webcasts.” A replay will be available on the Web site
following the presentation.
About Henry Schein
Henry Schein, a Fortune 500® company and a member of the
NASDAQ 100® Index, is recognized for its excellent customer
service and highly competitive prices. The Company’s four
business groups — Dental, Medical, International and Technology —
serve more than 600,000 customers worldwide, including dental
practitioners and laboratories, physician practices and animal
health clinics, as well as government and other institutions.
The Company operates through a centralized and automated
distribution network, which provides customers in more than 200
countries with a comprehensive selection of more than 90,000
national and Henry Schein private-brand products in stock, as well
as more than 100,000 additional products available as special-order
items. Henry Schein also provides exclusive, innovative
technology offerings for dental, medical and veterinary
professionals, including value-added practice management software
and electronic health record solutions.
Headquartered in Melville, N.Y., Henry Schein employs more than
13,500 people and has operations or affiliates in 23 countries.
The Company’s net sales reached a record $6.
‘/>”/>
